Dr. Reddy's Laboratories is set to take its complex generic drug named Fondaparinux sodium injection to Canada as well as two other emerging markets. The Alchemia Ltd. statement says that the Australian Pharmaceutical company that has tie-up for marketing with the city-based drug maker, Dr. Reddy's is expected to file for approval in up to four additional territories in 2014.
Dr. Reddy's Laboratories
Dr. Reddy’s began as an API manufacturer in 1984, producing high-quality APIs is the first Indian and later, the international markets. In 1987, we it started formulations operations and after becoming a force to reckon with in the Indian formulations market, it went international in 1991.
DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.